680 filings
Page 21 of 34
6-K
jnkx7y3i
3 May 17
Current report (foreign)
12:00am
6-K
57szuow cvos95b
25 Apr 17
Current report (foreign)
12:00am
6-K
7yuw93ch
24 Apr 17
RedHill Biopharma Announces Enrollment of Last Patient in the BEKINDA® Phase II Study for IBS-D
12:00am
6-K
9zjlmcy9 ajrzkf
20 Apr 17
RedHill Biopharma Announces Peer-Reviewed Publication of the Positive YELIVA® Phase I Study Results in Advanced Solid Tumors
12:00am
6-K
1ivwhatw5rmlpul
19 Apr 17
RedHill Biopharma to Host R&D Day on BEKINDA® for Acute Gastroenteritis and IBS-D
12:00am
6-K
dzpj83tsxp l4
18 Apr 17
Current report (foreign)
12:00am
6-K
vo9og7ybhu2zt5byv39w
13 Apr 17
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT® for Migraines in Luxembourg
12:00am
6-K
cgo9mso5ziyxq
5 Apr 17
Current report (foreign)
12:00am
6-K
t7blj5xxdcbs4cxl
4 Apr 17
RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma
12:00am
6-K
mm0h ypr1vei8y
3 Apr 17
Current report (foreign)
12:00am
6-K
im1ce4x
30 Mar 17
RedHill Biopharma to Present at BioCentury Future Leaders in the Biotech Industry Conference
12:00am
6-K
fbz ra7q3hnzsq
29 Mar 17
Current report (foreign)
12:00am
6-K
z0x xbpyyj9
22 Mar 17
RedHill Biopharma to Present at the 2017 MAP Conference
12:00am
6-K
6am6 ytb0qp
21 Mar 17
RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn’s Disease
12:00am
6-K
q5b1q71
13 Mar 17
RedHill Biopharma to Present at the BIO-Europe Spring 2017 Conference
12:00am
6-K
lt6sc
7 Mar 17
Current report (foreign)
12:00am
6-K
p00nl hwwp45610
23 Feb 17
RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Financial Results
12:00am
6-K
izofjy30jfq8ok4akq
23 Feb 17
RedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its Website
12:00am
6-K
56sf7dg
21 Feb 17
RedHill Biopharma Completes Treatment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis
12:00am
6-K
765mk76
16 Feb 17
Current report (foreign)
12:00am